Skip to main content
. 2022 Apr 25;10(3):e00177-22. doi: 10.1128/spectrum.00177-22

FIG 3.

FIG 3

FMT treatment alleviates blood vessel damage and increases pericyte coverage of microvessels after SCI. (A) Representative images showing double immunofluorescent staining for CD31 and PDGFRβ at the lesion epicenter. Scale bar = 50 μm. (B) The proportion of CD31-stained area was quantified 4 weeks post-injury on transverse sections. (C) Pericyte coverage was assessed as the ratio of PDGFRβ+ area to CD31+ area (n = 4). *, P < 0.05 compared to the SCI group; **, P < 0.01 compared to the SCI group.